International Synergies to Address Climate Change: Participatory Community Organizing in Toronto and the Baixada Fluminense, Brazil

This research was supported by the International Development Research Centre, grant numbe

Climate Justice Partnership Linking Universities and Community Organizations in Toronto, Durban, Maputo and Nairobi

This paper describes a project based at York University in Toronto, funded through the Climate Change Adaptation in Africa program of the International Development Research Centre and the UK Department for International Development (DFID), which is working to increase the participation of marginalized groups, especially women, in urban water governance.Students and faculty members from the University of Nairobi, Kenya; Eduardo Mondlane University in Maputo, Mozambique; and the University of KwaZulu-Natal in Durban, South Africa are working with civil society organizations in the three cities and with York University researchers to show how organizing in local communities can help the vulnerable to deal with climate change.As people in marginalized communities begin to address collectively the impacts of climate change, this summons political attention and allows those with direct experience to influence government policy. Civil society organizations, with support from local and international faculty and students, facilitate and focus this activism. University students help to document the NGOs’ work during internships with the NGOs. They also learn community development skills and make contacts. Faculty members publish and disseminate ideas about grassroots climate change adaptation and resulting political responses through presentations, publications and the project’s website (www.ccaa.irisyorku.ca)This research was supported by the International Development Research Centre, grant numbe

Constitutional Law—Regent\u27s Prayer Held Constitutional

Engel v. Vitale, 10 N.Y.2d 174, 218 N.Y.S.2d 659 (1961)

Evidence—Expert Need Not Testify as to the Reasons for His Opinion

People v. McDowell, 9 N.Y.2d 12, 210 N.Y.S.2d 514 (1961)

Criminal Law—Creation of A Fictional Citizen\u27s Arrest

People v. Foster, 10 N.Y.2d 99, 217 N.Y.S.2d 596 (1961)

Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and treated with Postoperative External Radiotherapy

Background: The causal link between elevated systemic inflammation biomarkers and poor survival has been demonstrated in cancer patients. However, the evidence for this correlation in endometrial cancer (EC) is too weak to influence current criteria of risk assessment. Here, we examined the role of inflammatory indicators as a tool to identify EC patients at higher risk of death in a retrospective observational study. Methods: A total of 155 patients surgically diagnosed with EC stage I-III FIGO 2009 and treated with postoperative External Beam Radiotherapy (EBRT) brachytherapy and chemotherapy according to ESMO-ESTRO-ESGO recommendation for patients at high risk of recurrence at the Gustave Roussy Institut, France, and Hospital Clínic, Spain, between 2008 and 2017 were evaluated. The impact of pre-treatment Neutrophil-to-Lymphocyte Ratio (NLR 2.2), Monocyte-to-Lymphocyte Ratio (MLR 0.18), Systemic Immune-Inflammatory Index (SII 1100) and lymphopenia (<1.0 109/L) on overall survival (OS), cancer-specific survival and progression-free survival was evaluated. Subsequently, a cohort of 142 patients within high-advanced risk groups according to ESMO-ESGO-ESTRO classification was evaluated. Results: On univariate analysis, NLR (HR = 2.2, IC 95% 1.1-4.7), SII (HR = 2.2, IC 95% 1.1-4.6), MLR (HR = 5.0, IC 95% 1.1-20.8) and lymphopenia (HR = 3.8, IC 95% 1.6-9.0) were associated with decreased OS. On multivariate analysis, NLR, MLR, SII and lymphopenia proved to be independent unfavorable prognostic factors. Conclusions: lymphopenia and lymphocytes-related ratio are associated with poorer outcome in surgically staged I-III FIGO EC patients classified as high risk and treated with adjuvant EBRT and could be considered at cancer diagnosis. External validation in an independent cohort is required before implementation for patients' stratification